A Food and Drug Administration advisory panel has recommended clearance for Medtronic's spin implant Amplify.
The FDA's Orthopedic and Rehabilitation Devices Panel vote 6-to-5 in favor of the device, which stimulates bone growth in spinal surgery patients. The FDA normally follows the advice of its panels, though it is not a requirement.
Medtronic makes a range of medical devices, including pacemakers, implantable defibrillators, and spinal implants.
Shares of Medtronic Inc., based in Minneapolis, fell 46 cents to $36.93 in afternoon trading on Wednesday.